Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the target of a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 69,600 shares, a drop of 7.4% from the July 31st total of 75,200 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily volume of 57,600 shares, the short-interest ratio is presently 1.2 days.
Eton Pharmaceuticals Stock Performance
Eton Pharmaceuticals stock opened at $4.60 on Wednesday. The firm has a market cap of $118.86 million, a price-to-earnings ratio of 115.00 and a beta of 1.29. Eton Pharmaceuticals has a 12 month low of $3.03 and a 12 month high of $5.81. The stock has a fifty day simple moving average of $3.75 and a two-hundred day simple moving average of $3.73.
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.05). Eton Pharmaceuticals had a negative return on equity of 43.62% and a negative net margin of 21.31%. The business had revenue of $9.07 million during the quarter, compared to the consensus estimate of $10.00 million.
Institutional Trading of Eton Pharmaceuticals
Eton Pharmaceuticals Company Profile
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.
Featured Articles
- Five stocks we like better than Eton Pharmaceuticals
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Small Cap Stocks That Insiders Are Buying
- Why Invest in 5G? How to Invest in 5G Stocks
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Consumer Staples Stocks, Explained
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Eton Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eton Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.